Prognostic significance of p53 abnormalities in colorectal carcinoma detected by PCR-SSCP and immunohistochemical analysis

被引:0
作者
Leahy, DT
Salman, R
Mulcahy, H
Sheahan, K
ODonoghue, DP
Parfrey, NA
机构
[1] ST VINCENTS HOSP, DEPT PATHOL, UCD, DUBLIN 4, IRELAND
[2] ST VINCENTS HOSP, DEPT GASTROENTEROL, DUBLIN 4, IRELAND
[3] UNIV COLL, DUBLIN, IRELAND
关键词
colorectal carcinoma; prognosis; PCR-SSCP; p53; protein; antigen retrieval;
D O I
10.1002/(SICI)1096-9896(199612)180:4<364::AID-PATH683>3.0.CO;2-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Abnormalities in the p53 tumour suppressor gene and in the expression of its protein are common in colorectal carcinoma, The prognostic significance of these p53 abnormalities was studied in 66 patients with colorectal cancer, followed for more than 10 years. Single-strand conformation polymorphism (SSCP) analysis was used to detect alterations in exons 5-8 of the p53 gene, Paraffin sections were examined immunohistochemically for p53 overexpression with the monoclonal antibody DO-7 (Dako) both with and without microwave antigen retrieval, Abnormalities of the p53 gene were found in 41 per cent of cases by SSCP analysis. Outcome was unrelated to SSCP abnormalities (P=0 . 19), except for the Dukes' A and B subgroup, where decreased survival was found in cases with abnormal SSCP (P=0 . 01). Overexpression of p53 protein was seen by immunohistochemistry in 47 per cent of cases without, and in 52 per cent of cases with microwave antigen retrieval, Immunohistochemical overexpression of p53 protein either with or without microwave antigen retrieval was an independent prognostic indicator of poor survival, These results suggest that for routine purposes, immunohistochemical detection of the p53 protein product may be more useful than SSCP analysis of the encoding p53 gene in identifying those at high risk of colorectal cancer recurrence and death.
引用
收藏
页码:364 / 370
页数:7
相关论文
共 32 条
  • [1] ASSOCIATION OF P53 PROTEIN EXPRESSION WITH TUMOR-CELL PROLIFERATION RATE AND CLINICAL OUTCOME IN NODE-NEGATIVE BREAST-CANCER
    ALLRED, DC
    CLARK, GM
    ELLEDGE, R
    FUQUA, SAW
    BROWN, RW
    CHAMNESS, GC
    OSBORNE, CK
    MCGUIRE, WL
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (03) : 200 - 206
  • [2] OVEREXPRESSION OF P53 AND LONG-TERM SURVIVAL IN COLON-CARCINOMA
    AUVINEN, A
    ISOLA, J
    VISAKORPI, T
    KOIVULA, T
    VIRTANEN, S
    HAKAMA, M
    [J]. BRITISH JOURNAL OF CANCER, 1994, 70 (02) : 293 - 296
  • [3] EVALUATION OF 6 ANTIBODIES FOR IMMUNOHISTOCHEMISTRY OF MUTANT P53 GENE-PRODUCT IN ARCHIVAL COLORECTAL NEOPLASMS
    BAAS, IO
    MULDER, JWR
    OFFERHAUS, GJA
    VOGELSTEIN, B
    HAMILTON, SR
    [J]. JOURNAL OF PATHOLOGY, 1994, 172 (01) : 5 - 12
  • [4] FAST AND SENSITIVE SILVER STAINING OF DNA IN POLYACRYLAMIDE GELS
    BASSAM, BJ
    CAETANOANOLLES, G
    GRESSHOFF, PM
    [J]. ANALYTICAL BIOCHEMISTRY, 1991, 196 (01) : 80 - 83
  • [5] PROGNOSTIC VALUE OF P53 OVEREXPRESSION AND C-KI-RAS GENE-MUTATIONS IN COLORECTAL-CANCER
    BELL, SM
    SCOTT, N
    CROSS, D
    SAGAR, P
    LEWIS, FA
    BLAIR, GE
    TAYLOR, GR
    DIXON, MF
    QUIRKE, P
    [J]. GASTROENTEROLOGY, 1993, 104 (01) : 57 - 64
  • [6] BURMER GC, 1989, CANCER RES, V49, P2141
  • [7] CARDER P, 1993, ONCOGENE, V8, P1397
  • [8] MUTATION OF THE P53 GENE PRECEDES ANEUPLOID CLONAL DIVERGENCE IN COLORECTAL-CARCINOMA
    CARDER, PJ
    CRIPPS, KJ
    MORRIS, R
    COLLINS, S
    WHITE, S
    BIRD, CC
    WYLLIE, AH
    [J]. BRITISH JOURNAL OF CANCER, 1995, 71 (02) : 215 - 218
  • [9] CUNNINGHAM J, 1992, CANCER RES, V52, P1974
  • [10] THE P53 TUMOR-SUPPRESSOR GENE AND TUMOR PROGNOSIS - IS THERE A RELATIONSHIP
    DOWELL, SP
    HALL, PA
    [J]. JOURNAL OF PATHOLOGY, 1995, 177 (03) : 221 - 224